Unlock instant, AI-driven research and patent intelligence for your innovation.

Bacterial response

A technology of bacteria and strains, applied in bioreactor/fermenter combination, special-purpose bioreactor/fermenter, laboratory container, etc.

Pending Publication Date: 2021-07-30
BIOFIRE DIAGNOSTICS LLC +1
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] While the FilmArray instrument has been used to identify various pathogens from a single sample, FilmArray, as well as other quantitative and semi-quantitative systems, may be suitable for detection of antibiotic susceptibility

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bacterial response
  • Bacterial response
  • Bacterial response

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0090] Antibiotic sensitivity can be measured at the molecular level by detecting transcriptional differences between susceptible and resistant bacteria in response to antibiotic exposure. These transcriptional differences can be illustratively discovered using RNA-sequencing or cDNA microarray analysis. The large multiplex and reverse transcription capabilities of multiplex systems such as the FilmArray system, as described above, can facilitate antibiotic susceptibility measurements for multiple bacteria and antibiotics. In this example, specific and general bacteria-antibiotic combinations were targeted after exposure to antibiotics to determine whether differences could be detected between susceptible and resistant strains. It is understood that such methods can be extended to other antibiotics or mixtures of antibiotics.

[0091] In prior art methods, both sensitive and resistant cultures were grown to early logarithmic phase and then exposed to antibiotics or no exposur...

Embodiment 2

[0114] The benchtop multiplex experiments described above demonstrate the feasibility of using measurements of cellular RNA concentrations of general antibiotic resistance genes and / or specific antibiotic resistance genes as antibiotic resistance tests. The ability to measure the concentration of, or detect the presence of, bacterial RNA transcripts is hampered by the fact that large numbers of these transcripts are present at concentrations well below one transcript / cell (Bartholomaus et al.). A practical consequence of this is that the concentration (copy / cell) of cellular genomic DNA (at least 1 copy / cell) often far exceeds the concentration of any cellular RNA transcript (often [RNA]). Under these conditions, removal of genomic DNA can help facilitate detection of RNA signals.

[0115] DNA removal can be accomplished using a variety of strategies, illustratively by modifying cell lysis conditions to enable selective release of RNA, modifying nucleic acid purification to s...

Embodiment 3

[0127] Although the FilmArray system is mentioned herein, other systems are suitable for the methods used herein. Certain embodiments of the invention may also relate to or include a PCR system configured to call from an amplification curve or a melting curve or a combination thereof. An illustrative example is described in US Patent No. 8,895,295, which has been incorporated by reference, for use with pouch 510 or similar embodiments. It should be understood, however, that the embodiments described in US Patent No. 8,895,295 are illustrative only and that other systems may be used in light of the present disclosure. For example, refer to Figure 10 , shows a block diagram of an illustrative system 700 including a control element 702, a thermal cycling element 708, and an optical element 710 in accordance with an exemplary aspect of the present disclosure.

[0128] In at least one embodiment, a system can include at least one PCR reaction mixture contained in a sample vessel...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Methods, sample vessels, and instruments are provided for determining antibiotic resistance of a bacterium.

Description

[0001] Cross References to Related Applications [0002] This application claims the benefit of and priority to US Application Serial No. 62 / 739,949, filed October 2, 2018, which is incorporated herein by reference in its entirety. Background technique [0003] Infectious diseases account for approximately 7% of human mortality in the United States, Canada, and Western Europe, and more than 40% of human mortality in developing regions. Infectious diseases result in a variety of clinical manifestations. Fever, pneumonia, meningitis, diarrhoea, and bloody diarrhoea are among the common overt manifestations. Although physical manifestations suggest some pathogens and eliminate others (as causative agents), a variety of potential causative agents remains, and a definitive diagnosis often requires the performance of various assays. Traditional microbiological techniques for diagnosing pathogens can take days or weeks, often delaying the proper course of treatment. [0004] In re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/689C12M1/38C12M1/34C12M1/02C12M1/00
CPCC12Q1/689C12Q1/18C12Q1/6809C12Q2600/158C12Q1/686C12Q2521/107C12Q2531/113C12Q2565/629B01L3/502B01L2300/087B01L2300/18C12Q1/6806C12Q1/6851
Inventor R·J·克里斯普A·C·赫默特S·马克斯雷特E·罗L·E·P·德拉泽克M·F·霍金J·E·杰克逊
Owner BIOFIRE DIAGNOSTICS LLC